Covered recipient · General Payments record
MARK DAVID POPHAL
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$2,264.35
- Reported across 121 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $556.98 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $112.76 | 7 |
| Alcon Laboratories Inc | $95.32 | 4 |
| Dompe US, Inc. | $84.27 | 4 |
| Amgen Inc. | $81.57 | 3 |
| Oyster Point Pharma, Inc. | $74.36 | 3 |
| Bausch & Lomb Americas Inc. | $40.51 | 2 |
| Harrow Eye, LLC | $29.82 | 1 |
| Tarsus Pharmaceuticals, Inc. | $21.76 | 1 |
| NEW WORLD MEDICAL,INC. | $16.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.65 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105293779 | CMS |
| ABBVIE INC. | $15.99 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105293783 | CMS |
| ABBVIE INC. | $13.93 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105293788 | CMS |
| ABBVIE INC. | $17.99 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105293792 | CMS |
| ABBVIE INC. | $14.16 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105293796 | CMS |
| ABBVIE INC. | $18.55 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105293799 | CMS |
| ABBVIE INC. | $13.49 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105293804 | CMS |
| Alcon Vision LLC | $22.04 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110563959 | CMS |
| Alcon Vision LLC | $24.51 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110563961 | CMS |
| Alcon Vision LLC | $21.64 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110563957 | CMS |
| Alcon Vision LLC | $27.13 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110563963 | CMS |
| Amgen Inc. | $32.76 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111678710 | CMS |
| Amgen Inc. | $25.41 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111678712 | CMS |
| Amgen Inc. | $23.40 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111678714 | CMS |
| Bausch & Lomb Americas Inc. | $21.11 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140403788 | CMS |
| Bausch & Lomb Americas Inc. | $19.40 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140403790 | CMS |
| Dompe US, Inc. | $25.32 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151410545 | CMS |
| Dompe US, Inc. | $20.16 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151410547 | CMS |
| Dompe US, Inc. | $21.54 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151410549 | CMS |
| Dompe US, Inc. | $17.25 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151410551 | CMS |
| Harrow Eye, LLC | $29.82 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145612646 | CMS |
| NEW WORLD MEDICAL,INC. | $16.61 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137401139 | CMS |
| Oyster Point Pharma, Inc. | $24.60 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147416496 | CMS |
| Oyster Point Pharma, Inc. | $25.80 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147403562 | CMS |
| Oyster Point Pharma, Inc. | $23.96 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147406976 | CMS |
| Tarsus Pharmaceuticals, Inc. | $21.76 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139125438 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.